+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Is 5-aminolevulinic acid involved in the hepatocellular carcinogenesis of acute intermittent porphyria?

Is 5-aminolevulinic acid involved in the hepatocellular carcinogenesis of acute intermittent porphyria?

Cellular and Molecular Biology 48(1): 17-26

5-Aminolevulinic acid (ALA) is a heme precursor that accumulates in acute intermittent porphyria (AIP) due to enzymatic deficiencies in the heme biosynthetic pathway. Its accumulation has been associated with several symptoms, such as abdominal pain attacks, neuromuscular weaknesses, neuropsychiatric alterations and increased hepatocellular carcinoma (HCC) incidence. The use of exogenous ALA to elevate porphyrin levels in tumor photodynamic therapy, adds further significance to ALA toxicology. Under ferritin mediated and metal catalyzed oxidation, ALA produces reactive oxygen species that can damage plasmid and isolated DNA in vitro, and increases the steady-state level of 8-oxo-7,8-dihydro-2'-deoxyguanosine in liver, spleen and kidney DNA and 5-hydroxy-2'-deoxycytidine in liver DNA of ALA-treated rats. The in vitro DNA damage could be partially inhibited by SOD, catalase, DTPA, mannitol and melatonin. ALA also promotes the formation of radical-induced base degradation products in isolated DNA. 4,5-Dioxovaleric acid, the final oxidation product of ALA, alkylates guanine moieties within both nucleoside and isolated DNA, producing two diastereoisomeric adducts. Dihydropyrazine derivatives of ALA generated by its dimerization, promote DNA strand-breaks and 8-oxodGuo formation in the presence of Cu2+. Together these results reinforce the hypothesis that the DNA damage induced by ALA may be associated with the development of HCC in individuals suffering from AIP.

(PDF emailed within 1 workday: $29.90)

Accession: 010885923

Download citation: RISBibTeXText

PMID: 11930945

Related references

Tyrosinemia with acute intermittent porphyria: aminolevulinic acid dehydratase deficiency related to elevated urinary aminolevulinic acid levels. Journal of Pediatrics 90(3): 400-404, 1977

Delta-aminolevulinic acid, porphobilinogen, and porphyrin excretion throughout pregnancy in a patient with acute intermittent porphyria with passive porphyria in the infant. Jour Lab And Clin Med 58(3): 437-444, 1961

The possible involvement of 5-aminolevulinic acid in the primary liver cancer in acute intermittent porphyria. Mutation Research 483(Suppl 1): S91, 20 October, 2001

Oxidative stress in acute intermittent porphyria and lead poisoning may be triggered by 5-aminolevulinic acid. Brazilian Journal of Medical and Biological Research 29(7): 841-851, 1996

A model for acute intermittent porphyria effects of 5 aminolevulinic acid on ventral root activity in the hemisected hamster spinal cord. Molecular Aspects of Medicine 11(1-2): 53-54, 1990

Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria. Clinical Chemistry 52(4): 650-656, 2006

On the problem of treatment of acute intermittent porphyria with ovulation inhibitors. (Studies of delta-aminolevulinic acid, porphobilinogen and total porphyrin excretion). Klinische Wochenschrift 46(20): 1114-1116, 1968

Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion. Clinical Chemistry 52(4): 701-707, 2006

Damage to rat liver mitochondria promoted by delta-aminolevulinic acid-generated reactive oxygen species: connections with acute intermittent porphyria and lead-poisoning. Biochimica et Biophysica Acta 1056(1): 57-63, 1991

Investigations on the formation of urinary coproporphyrin isomers I-IV in 5-aminolevulinic acid dehydratase deficiency porphyria, acute lead intoxication and after oral 5-aminolevulinic acid loading. Clinical Biochemistry 32(2): 119-123, March, 1999

Screening for hepatocellular carcinoma in acute intermittent porphyria. Journal of Internal Medicine 270(4): 398; Author Reply 397-398; Author Reply 397, 2011

Hepatocellular carcinoma in patients with acute intermittent porphyria. Acta Medica Scandinavica 215(3): 271-274, 1984

The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria. Journal of Internal Medicine 240(4): 195-201, 1996